7-((6-isopropoxypyridin-3-ylsulfonyl)methyl)-2,3,4,5-tetrahydro-1H-benzo[d]azepine

ID: ALA1078461

PubChem CID: 46882794

Max Phase: Preclinical

Molecular Formula: C19H24N2O3S

Molecular Weight: 360.48

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC(C)Oc1ccc(S(=O)(=O)Cc2ccc3c(c2)CCNCC3)cn1

Standard InChI:  InChI=1S/C19H24N2O3S/c1-14(2)24-19-6-5-18(12-21-19)25(22,23)13-15-3-4-16-7-9-20-10-8-17(16)11-15/h3-6,11-12,14,20H,7-10,13H2,1-2H3

Standard InChI Key:  BMTKUMNAVZOJQX-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 25 27  0  0  0  0  0  0  0  0999 V2000
    6.1360   -5.3848    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1347   -6.2087    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8530   -6.6221    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8510   -4.9716    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3639   -5.8009    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.0084   -5.0540    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2055   -4.8705    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0063   -6.5409    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2023   -6.7238    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5618   -6.2064    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5608   -5.3809    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4195   -6.6216    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7043   -6.2087    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.9890   -6.6215    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2840   -5.4904    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.1098   -5.4904    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.2756   -6.2077    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5609   -6.6200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5603   -7.4467    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2806   -7.8594    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.9924   -7.4449    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8457   -7.8605    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.1300   -7.4485    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4152   -7.8623    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1289   -6.6226    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  4  1  1  0
  5  6  1  0
  2 12  1  0
  6  7  1  0
 12 13  1  0
  5  8  1  0
 13 14  1  0
  9 10  1  0
 13 15  2  0
 10 11  1  0
 13 16  2  0
 11  7  1  0
 14 17  2  0
  8  9  1  0
 17 18  1  0
  2  3  1  0
 18 19  2  0
 19 20  1  0
  3 10  2  0
 20 21  2  0
 21 14  1  0
 19 22  1  0
 22 23  1  0
  1  2  2  0
 23 24  1  0
 11  4  2  0
 23 25  1  0
M  END

Associated Targets(Human)

CYP2D6 Tclin Cytochrome P450 2D6 (33882 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GHSR Tclin Ghrelin receptor (6229 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MLNR Tchem Motilin receptor (1724 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 360.48Molecular Weight (Monoisotopic): 360.1508AlogP: 2.53#Rotatable Bonds: 5
Polar Surface Area: 68.29Molecular Species: BASEHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 9.86CX LogP: 2.57CX LogD: 0.18
Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.89Np Likeness Score: -1.36

References

1. Bailey JM, Scott JS, Basilla JB, Bolton VJ, Boyfield I, Evans DG, Fleury E, Heightman TD, Jarvie EM, Lawless K, Matthews KL, McKay F, Mok H, Muir A, Orlek BS, Sanger GJ, Stemp G, Stevens AJ, Thompson M, Ward J, Vaidya K, Westaway SM..  (2009)  The discovery and optimisation of benzazepine sulfonamide and sulfones as potent agonists of the motilin receptor.,  19  (22): [PMID:19804969] [10.1016/j.bmcl.2009.09.027]

Source